Vontobel Holding
BEAM icon

Vontobel Holding’s Beam Therapeutics BEAM Stock Holding History

Vontobel Holding’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638K Buy
26,774
+8,722
+48% +$242K ﹤0.01% 765
2025
Q4 		$500K Buy
+18,052
New +$461K ﹤0.01% 994
2022
Q1 		– Sell
-12,993
Closed -$1.03M – 1060
2021
Q4 		$1.03M Sell
12,993
-125
-1% -$10.7K 0.01% 623
2021
Q3 		$1.14M Sell
13,118
-230
-2% -$23.1K 0.01% 584
2021
Q2 		$1.72M Sell
13,348
-12,566
-48% -$1M 0.01% 475
2021
Q1 		$2.07M Buy
+25,914
New +$2.47M 0.02% 389

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vontobel Holding's BEAM Position: Q1 2026 in Review

Vontobel Holding increased its Beam Therapeutics (BEAM) stake by 48% in Q1 2026, buying an estimated $242K and bringing the position to 26,774 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Vontobel Holding first reported a position in BEAM in Q1 2021 and has held it in 6 quarters since. The position peaked at $2.07M in Q1 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Vontobel Holding held 26,774 shares of Beam Therapeutics worth $638K as of Q1 2026.
  • Vontobel Holding bought 8,722 Beam Therapeutics shares in Q1 2026, an estimated $242K.
  • Beam Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #765 holding.
  • Vontobel Holding first reported a position in Beam Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • Vontobel Holding's Beam Therapeutics position peaked at $2.07M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.